Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Expands By 1,045.5%

PURE Bioscience, Inc. (OTCMKTS:PUREGet Rating) was the target of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 37,800 shares, a growth of 1,045.5% from the March 15th total of 3,300 shares. Based on an average daily trading volume, of 137,800 shares, the days-to-cover ratio is presently 0.3 days.

Shares of OTCMKTS:PURE opened at $0.20 on Wednesday. The firm has a 50 day moving average of $0.19 and a 200 day moving average of $0.26. The company has a market capitalization of $17.57 million, a price-to-earnings ratio of -5.00 and a beta of -0.08. PURE Bioscience has a 52 week low of $0.16 and a 52 week high of $0.70.

PURE Bioscience (OTCMKTS:PUREGet Rating) last announced its earnings results on Tuesday, March 15th. The company reported ($0.01) earnings per share (EPS) for the quarter. PURE Bioscience had a negative net margin of 130.17% and a negative return on equity of 107.81%. The business had revenue of $0.42 million for the quarter.

About PURE Bioscience (Get Rating)

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.

Read More

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.